Insider Transactions in Q3 2022 at Corcept Therapeutics Inc (CORT)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2022
|
Hazel Hunt Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
29,997
-29.08%
|
$779,922
$26.04 P/Share
|
|
Sep 28
2022
|
Hazel Hunt Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+32.65%
|
$100,000
$2.08 P/Share
|
|
Sep 07
2022
|
Gary Charles Robb Chief Business Officer |
SELL
Open market or private sale
|
Direct |
50,000
-50.23%
|
$1,300,000
$26.06 P/Share
|
|
Sep 01
2022
|
Gary Charles Robb Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,020
+1.01%
|
$24,240
$12.99 P/Share
|
|
Sep 01
2022
|
Sean Maduck |
BUY
Grant, award, or other acquisition
|
Direct |
1,844
+1.62%
|
$22,128
$12.99 P/Share
|
|
Sep 01
2022
|
Sean Maduck |
SELL
Open market or private sale
|
Direct |
25,000
-31.4%
|
$625,000
$25.84 P/Share
|
|
Sep 01
2022
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+23.9%
|
$75,000
$3.29 P/Share
|
|
Sep 01
2022
|
Atabak Mokari Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,586
+41.67%
|
$19,032
$12.99 P/Share
|
|
Sep 01
2022
|
William Guyer Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,844
+41.67%
|
$22,128
$12.99 P/Share
|
|
Aug 30
2022
|
Gary Charles Robb Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
93,922
-49.06%
|
$2,441,972
$26.14 P/Share
|
|
Aug 30
2022
|
Gary Charles Robb Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
167,323
+46.64%
|
$334,646
$2.08 P/Share
|
|
Aug 19
2022
|
Sean Maduck |
SELL
Payment of exercise price or tax liability
|
Direct |
406
-0.74%
|
$10,962
$27.6 P/Share
|
|
Aug 19
2022
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+21.42%
|
$30,000
$2.24 P/Share
|
|
Aug 12
2022
|
Sean Maduck |
SELL
Exercise of conversion of derivative security
|
Direct |
24,800
-38.26%
|
$694,400
$28.7 P/Share
|
|
Aug 12
2022
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
24,800
+17.61%
|
$49,600
$2.61 P/Share
|
|
Aug 09
2022
|
Sean Maduck |
SELL
Open market or private sale
|
Direct |
200
-0.5%
|
$5,600
$28.7 P/Share
|
|
Aug 09
2022
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+0.49%
|
$200
$1.92 P/Share
|
|
Aug 08
2022
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
15,385
-100.0%
|
$430,780
$28.32 P/Share
|
|
Aug 08
2022
|
Daniel N Swisher Jr |
SELL
Payment of exercise price or tax liability
|
Direct |
4,615
-23.08%
|
$129,220
$28.39 P/Share
|
|
Aug 08
2022
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
$120,000
$6.55 P/Share
|
|
Jul 18
2022
|
Sean Maduck |
SELL
Open market or private sale
|
Direct |
25,000
-38.45%
|
$675,000
$27.37 P/Share
|
|
Jul 18
2022
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+16.07%
|
$50,000
$2.0 P/Share
|
|
Jul 07
2022
|
Joseph K Belanoff Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
55,111
-2.17%
|
$1,432,886
$26.26 P/Share
|
|
Jul 06
2022
|
Gary Charles Robb Chief Business Officer |
SELL
Open market or private sale
|
Direct |
45,000
-65.1%
|
$1,170,000
$26.0 P/Share
|
|
Jul 06
2022
|
Gary Charles Robb Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,677
+32.1%
|
$65,354
$2.08 P/Share
|
|
Jul 06
2022
|
Joseph K Belanoff Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
279,908
-9.93%
|
$7,277,608
$26.27 P/Share
|
|
Jul 06
2022
|
Joseph K Belanoff Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
451,189
-56.4%
|
$11,730,914
$26.21 P/Share
|
|
Jul 06
2022
|
Joseph K Belanoff Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
800,000
+50.0%
|
$1,600,000
$2.08 P/Share
|